Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers. I. Molecular biomarkers in …

TL Lotan, SA Tomlins, TA Bismar… - The American journal …, 2020 - journals.lww.com
The combined clinical and molecular heterogeneity of prostate cancer necessitates the use
of prognostic, predictive, and diagnostic biomarkers to assist the clinician with treatment …
被引用次数：55 相关文章

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers …

TL Lotan, SA Tomlins, TA Bismar… - … journal of surgical …, 2020 - pubmed.ncbi.nlm.nih.gov
The combined clinical and molecular heterogeneity of prostate cancer necessitates the use
of prognostic, predictive, and diagnostic biomarkers to assist the clinician with treatment …

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers …

TL Lotan, SA Tomlins, TA Bismar… - The American journal …, 2020 - boris.unibe.ch
The combined clinical and molecular heterogeneity of prostate cancer necessitates the use
of prognostic, predictive, and diagnostic biomarkers to assist the clinician with treatment …

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers …

TL Lotan, SA Tomlins, TA Bismar… - The American Journal …, 2020 - europepmc.org
The combined clinical and molecular heterogeneity of prostate cancer necessitates the use
of prognostic, predictive, and diagnostic biomarkers to assist the clinician with treatment …

Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers …

TL Lotan, SA Tomlins, TA Bismar… - American Journal of …, 2020 - pure.johnshopkins.edu
The combined clinical and molecular heterogeneity of prostate cancer necessitates the use
of prognostic, predictive, and diagnostic biomarkers to assist the clinician with treatment …

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers …

TL Lotan, SA Tomlins, TA Bismar… - The American journal …, 2020 - folia.unifr.ch
English The combined clinical and molecular heterogeneity of prostate cancer necessitates
the use of prognostic, predictive, and diagnostic biomarkers to assist the clinician with …

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers …

TL Lotan, SA Tomlins, TA Bismar… - The American journal of …, 2020 - sonar.ch
English The combined clinical and molecular heterogeneity of prostate cancer necessitates
the use of prognostic, predictive, and diagnostic biomarkers to assist the clinician with …

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers …

TL Lotan, SA Tomlins, TA Bismar… - … American Journal of …, 2020 - ingentaconnect.com
The combined clinical and molecular heterogeneity of prostate cancer necessitates the use
of prognostic, predictive, and diagnostic biomarkers to assist the clinician with treatment …